BioStock: WntResearch's new CEO on joining the company and the Phase II study

In the spring, the Malmö-based research company WntResearch paused the patient recruitment for its phase II study with candidate Foxy-5 due to the Covid-19 pandemic. In early October, the company announced the hiring of Anders Rabbe as acting CEO. His first assignment will be to ensure recruitment for the ongoing study. BioStock has spoken with the new CEO to get his view on his new role and what awaits WntResearch.

Read the full interview at biostock.se:

https://www.biostock.se/en/wntresearchs-new-ceo-on-joining-the-company-and-the-phase-ii-study/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se